evolva holding sa (EVE:SIX Swiss Ex)

Executive Profile*

Background*

Sir Thomas Fulton Wilson McKillop, Tom, Ph.D. serves as Vice President of the European Federation for Pharmaceutical Industries and Associations. Sir McKillop served as Chief Executive Officer of AstraZeneca PLC from 1999 to December 2005. He served as Chief Executive Officer of Zeneca Pharmaceuticals from 1994 to 1999. He has more than 35 years of experience from management positions in the pharmaceutical industry. He held a number of senior and general management appointments ... with ICI before the demerger in 1993, when Zeneca Group PLC was created. In 1975, he joined ICI's Pharmaceuticals Division where he held a number of positions over the next 14 years, including Technical Director with international responsibility for research, development and production from 1989 to April 1992 and its Deputy Chief Executive Officer since May 1992. Since 1978, he served as Research Director of ICI's French pharmaceuticals division. On his return to the UK, he held a number of positions in ICI Pharmaceuticals in chemistry and research and development from 1980 to 1989. Sir McKillop has been Chairman of Evolva Holding SA since May 9, 2012. Sir McKillop served as Chairman of the Board and Director at National Westminster Bank plc. He served as Chairman of Royal Bank of Scotland Group Plc, a parent company of Ulster Bank Group from April 28, 2006 to February 2009. He served as Deputy Chairman of Royal Bank of Scotland Group PLC since September 1, 2005 and ICI Pharmaceuticals. Sir McKillop has been a Non-Executive Director of BP Trinidad & Tobago since LLC June 2004 and BP Solar International Inc. since July 1, 2004. He has been Non Executive Director of Scotland Group Plc., since September 1, 2005 and Centre de Mecanique Ondulatoire Appliquee (Paris). He serves as Non-executive Director of Almirall Prodesfarma. He has been a Director of Evolva Holding SA. since June 10, 2010. He serves as a Member of International Advisory Board of Scottish Development International. He serves as a Member of Advisory Board of The British-American Business Council. Sir McKillop has been Independent External Director of Laboratorios Almirall SA since May 29, 2009. He has been an Independent Director at UCB SA since November 2009. He served as an Executive Director of the Zeneca Group since 1996. Sir McKillop served as an Executive Director of AstraZeneca PLC from January 1, 1996 to December 31, 2005. He served as Non-Executive Director of Royal Bank of Scotland Group plc from September 1, 2005 to April 2009. He served as a Non-Executive Director of Lloyds Banking Group plc (formerly, Lloyds TSB Group PLC) from 1999 to December 31, 2004 and BP PLC from July 2004 to April 16, 2009. Sir McKillop served as a Director of Laboratorios Almirall SA since June 2007. He served as a Director of Aptium Oncology (formerly, Salick Health Care, Inc) since 1995. He served as a Non-Executive Director of Amersham International. Sir McKillop is also Pro-Chancellor of Leicester University, UK, and Chairman of the British Pharma Group and the NorthWest Science Council. Since June 2002, he served as President of the European Federation of Pharmaceutical Industries and Associations (E.F.P.I.A.) at its General Assembly in Bruges, with a two-year mandate. Sir McKillop is a fellow of the Royal Society, President of The Science Council, and a Trustee of the Council for Industry and Higher Education. He joined ICI's Corporate Research Laboratory in 1969, following post-doctorate research work. He received his knighthood in the 2002 Queen's Birthday honor’s list for services to the pharmaceuticals industry. Sir McKillop obtained a Ph.D. and B.Sc. Honors in Chemistry from Irvine Royal Academy, Glasgow University. Sir McKillop educated at Irvine Royal Academy, Glasgow University and Centre de Mecanique Ondulatoire Appliquee (Paris).

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
EVE:SW	SFr.0.76 CHF	+0.02

COMPETITOR COMPENSATION